Inhibrx Biosciences Inc.
USD87.61
+3.52 (+4.19%)
CEO
Mark Lappe
IPO Date
2024-05-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$83.76
Prev. Close
$84.09
Day Low
$83.75
Day High
$88.64
52W Low
$20.55
52W High
$155.29
Market Cap
$1.29B
Volume
0.14M
| 15,000 |
| $95.22 |
| 4 Jun 2026 | FORSYTH DOUGLAS | director | A-Award | Acquired | 15,000 | $95.22 |
| 4 Jun 2026 | MANHARD KIMBERLY | director | A-Award | Acquired | 15,000 | $95.22 |
| 27 Apr 2026 | Matly David | President | A-Award | Acquired | 50,000 | $129.06 |
| 9 Oct 2025 | VIKING GLOBAL INVESTORS LP | 10 percent owner | S-Sale | Disposed | 308,643 | $32.25 |
| 9 Oct 2025 | VIKING GLOBAL INVESTORS LP | 10 percent owner | S-Sale | Disposed | 16,315 | $32.25 |
| 9 Oct 2025 | VIKING GLOBAL INVESTORS LP | 10 percent owner | S-Sale | Disposed | 25,042 | $32.25 |
| 29 May 2025 | MANHARD KIMBERLY | director | A-Award | Acquired | 15,000 | $12.91 |
| 29 May 2025 | Vuori Kristiina MD | director | A-Award | Acquired | 15,000 | $12.91 |